PJ017

N/A

Report date: 2026/02/02 20:01:46

Base Information

Drug NamePJ017
Drug Alias Name聚乙二醇化重组门冬酰胺酶PJ017PJ-017
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionAspartate-ammonia ligase inhibitorsAsparagine inhibitorsAmidohydrolases stimulants
TargetsAspartate-ammonia ligaseAsparagineAmidohydrolases
Therapy Area/IndicationsT lymphoblastic lymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChongqing Peg-Bio Biopharm Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesChongqing Peg-Bio Biopharm Co Ltd
Inactive CompaniesN/A
Active IndicationsT lymphoblastic lymphomaPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A